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ABSTRACT
Background: The accurate estimation of the prevalence of vitamin
A deficiency (VAD) is important in planning and implementing
interventions. Retinol-binding protein (RBP) is often used in pop-
ulation surveys to measure vitamin A status, but its interpretation is
challenging in settings where inflammation is common because
RBP concentrations decrease during the acute-phase response.
Objectives: We aimed to assess the relation between RBP concen-
trations and inflammation and malaria in preschool children (PSC)
(age range: 6–59 mo) and women of reproductive age (WRA) (age
range: 15–49 y) and to investigate adjustment algorithms to account
for these effects.
Design: Cross-sectional data from 8 surveys for PSC (n = 8803) and
4 surveys for WRA (n = 4191) from the Biomarkers Reflecting
Inflammation and Nutritional Determinants of Anemia (BRINDA)
project were analyzed individually and combined with the use of a
meta-analysis. Several approaches were explored to adjust RBP
concentrations in PSC in inflammation and malaria settings as fol-
lows: 1) the exclusion of subjects with C-reactive protein (CRP)
concentrations .5 mg/L or a-1-acid glycoprotein (AGP) concen-
trations .1 g/L, 2) the application of arithmetic correction fac-
tors, and 3) the use of a regression correction approach. The impact
of adjustment on the estimated prevalence of VAD (defined as
,0.7 mmol/L) was examined in PSC.
Results: The relation between estimated VAD and CRP and AGP
deciles followed a linear pattern in PSC. In women, the correlations
between RBP and CRP and AGP were too weak to justify adjust-
ments for inflammation. Depending on the approach used to adjust
for inflammation (CRP+AGP), the estimated prevalence of VAD de-
creased by a median of 11–18 percentage points in PSC compared
with unadjusted values. There was no added effect of adjusting for
malaria on the estimated VAD after adjusting for CRP and AGP.
Conclusions: The use of regression correction (derived from inter-
nal data), which accounts for the severity of inflammation, to esti-
mate the prevalence of VAD in PSC in regions with inflammation
and malaria is supported by the analysis of the BRINDA data. These
findings contribute to the evidence on adjusting for inflammation
when estimating VAD with the use of RBP. Am J Clin Nutr
2017;106(Suppl):390S–401S.
Keywords: anemia, inflammation, meta-analysis, nutritional
assessment, retinol-binding protein, vitamin A deficiency
INTRODUCTION
Vitamin A deficiency (VAD) is a widespread public-health
problem with the most vulnerable groups being preschool children
(PSC), women of reproductive age (WRA), and pregnant women (1).
Vitamin A has a role in many biological functions including growth,
vision, epithelial differentiation, immune function, and reproduction
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(2). VAD is the leading cause of preventable blindness in children
and night blindness in pregnant women and increases the risks of
disease and death from infections especially in PSC (2, 3).
Serum retinol concentrations reflect liver vitamin A stores only
when liver stores are severely depleted (, 0.07 mmol/g liver) or
extremely high (.1.05 mmol/g liver) (4). However, the pop-
ulation distribution of serum retinol concentrations or its carrier
retinol-binding protein (RBP) or the prevalence of individuals
with serum retinol or RBP concentrations ,0.7 mmol/L can
provide important information about the vitamin A status of a
population and may reflect the severity of VAD as a public-
health problem (5). Studies have shown an w1:1 relation be-
tween serum retinol and RBP, and therefore, RBP is often
substituted as an indicator of vitamin A status (6) with the ad-
vantage of RBP being more robust for sample collection and
handling processes and less expensive to measure (7).
Inflammation and nutrition are closely related (8) with the
result that many nutritional biomarkers, such as serum retinol and
RBP, are altered in the presence of inflammation (9). During the
inflammatory process, there are rapid and large changes in the
plasma concentrations of retinol and RBP, the latter of which is
itself a negative acute-phase protein (APP) (10). Two of the most
commonly measured APPs to reflect an individual’s inflamma-
tory response in cross-sectional surveys are C-reactive protein
(CRP), which rises rapidly and acutely in response to an inflam-
matory stimulus, and a-1-acid glycoprotein (AGP), which has a
slower and longer response (11, 12).
To our knowledge, there are few studies in which biomarkers
of vitamin A have been measured before, during, and after
physical trauma. Louw et al. (10) studied the “natural history” of
blood vitamin concentration status in adults who were un-
dergoing elective surgery and showed that plasma concentra-
tions of retinol and RBP decreased significantly by 48 h and
mirrored the changes in CRP. These changes were transient, and
serum retinol and RBP concentrations returned to preoperation
concentrations 7 d postsurgery (10).
The regions with the highest prevalence of VAD often also
have the greatest burden of malaria. This association is important
because the effects of malaria on vitamin A status can be cat-
egorized by transient reductions from decreased RBP synthesis
by the liver, decreased release of the retinol-RBP complex into
the circulation, and leakage into the extravascular space because
of increased vascular permeability (12–14). Some of these ef-
fects may be mediated by the acute-phase response; however,
the specific contribution of malaria infection in temporarily al-
tering serum retinol or RBP concentrations beyond the acute-
phase response is unclear.
In surveys of RBP, an important question is whether to account
for inflammation in estimating the prevalence of VAD and, if so,
by what approach. One option is to exclude respondents with
elevated APP values; however, the proportion of individuals with
elevated APPs can be high in some populations, and thus, the
exclusion of these individuals leads to less precision. To address
this issue, Thurnham et al. (15) conducted a meta-analysis to
generate correction factors (CFs) to adjust individuals’ serum
retinol concentrations on the basis of 4 stages of subclinical
infection. A more recent approach suggests removing the effect
of inflammation on retinol or RBP with the use of a regression
approach (16, 17). No consensus has been reached on which
approach should be applied to interpret serum retinol or RBP
concentrations to account for inflammation in the assessment of
vitamin A status in populations. The WHO has no recommendation
on how to adjust serum retinol or RBP for inflammation (5).
To better inform nutrition programs and policies, the current
study describes different approaches to adjust RBP and estimate
the prevalence of VAD in PSC and nonpregnant WRA in settings
with a high prevalence of inflammation. In this paper, the fol-
lowing 4 questions are explored: 1) Is there a need to measure
biomarkers of inflammation when RBP is used as an indicator of
VAD? 2) Is there a need to measure .1 inflammation biomarker
(CRP and AGP) to adjust RBP? 3) Is an additional adjustment
needed to correct RBP concentrations in the presence of ma-
laria? and 4) How do the different adjustment approaches for
correcting for inflammation and for calculating the estimated
prevalence of VAD compare with each other?
METHODS
We used surveys from the Biomarkers Reflecting Inflamma-
tion and Nutritional Determinants of Anemia (BRINDA) project
(www.BRINDA-nutrition.org) (17). The BRINDA protocol was
reviewed by the institutional review boards of the NIH and was
deemed to be non–human subjects research. The methods for
identifying data sets, inclusion and exclusion criteria, and data
management for the BRINDA project have been described in the
methodologic overview in this supplement, which is an open
access publication (18). Briefly, the surveys were nationally or
regionally representative, and the inclusion criteria were as fol-
lows: 1) surveys were conducted after 2004, 2) target groups
included PSC and/or nonpregnant WRA, and 3) surveys measured
$1 marker of iron (ferritin or soluble transferrin receptor) or
vitamin A status (RBP or retinol) and$1 marker of inflammation
(AGP or CRP). Surveys that were included in this analysis were
those with measures of RBP and inflammation (CRP and/or
AGP). Originally, surveys that measured serum retinol were also
included; however, only 4 surveys measured retinol, 2 surveys of
which measured only CRP, and the other 2 surveys measured only
AGP. Because of the lack of comparability between the surveys
that included serum retinol, only surveys that measured RBP are
presented here. Of the 16 PSC and 10 WRA BRINDA data sets,
data from 8 PSC and 4 WRA data sets were available for analysis
for this paper. In all surveys in which WRA data were collected,
PSC data were also collected as part of the same surveys. Both
CRP and AGP were measured in all data sets, and malaria was
measured in 5 PSC and 3 WRA data sets.
Laboratory analysis
Venous or capillary blood was collected from each respondent,
and plasma or serum was stored at 2208C until analysis; one
survey used dried blood spots. RBP, CRP, and AGP concentra-
tions were assessed with the use of a sandwich ELISA at the
VitMin Laboratory in all data sets (7). Current malaria was as-
sessed with the use of microscopy in Kenya and Coˆte d’Ivoire
(19), and current or recent malaria was assessed with the use of
the Paracheck Pf rapid diagnostic test (Orchid Biomedical
System) in Liberia and plasma histidine rich protein 2 (Cellabs
Pty Ltd.) in Cameroon. Additional information on laboratory
methods is further described in the methodologic overview in
this supplement (18).
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Case definitions
RBP concentrations ,0.7 mmol/L in PSC (5) were used to
define VAD, and RBP concentrations ,1.05 mmol/L in WRA
were used to define vitamin A insufficiency (VAI) (20–24). The
use of a concentration cutoff of ,0.7 mmol/L in WRA resulted
in a prevalence of VAD #2% across all surveys. Malaria was
defined as either positive or negative. Inflammation was defined
as a CRP concentration .5 mg/L and/or AGP concentration
.1 g/L (7, 15).
The household socioeconomic status asset score was defined
by survey investigators who applied a principal component
analysis within each survey to household characteristics and item
ownership for comparison of the poorest wealth quintile to the
higher wealth quintiles. Maternal education was defined as any
school compared with no school.
Statistical analysis
Descriptive statistics were calculated with the use of SAS 9.4
software (SAS Institute) and cross-checked with SAS or STATA
12.0 software (StataCorp). Correlations between RBP, CRP, and
AGP concentrations and malaria were calculated with the use of
Kendall’s t coefficient with the SOMERSD package (25). The
Taylor linearization method was used to obtain unbiased esti-
mates that incorporated the sampling weight, strata, and clus-
ter (as applicable) when analyzing individual surveys. First,
individual survey analyses, accounting for the complex survey
design, were done with the use of the survey package in R 3.2.2
software (R Core Team) (26). Individual survey estimates were
combined with the use of a meta-analysis approach with the
metafor package in R 3.2.2 software (R Core Team) (27, 28).
The heterogeneity of estimates across the surveys was assessed
with the use of Cochrane’s heterogeneity test (27, 28).
The prevalences of VAD and VAI were estimated without any
adjustments to RBP and were referred to as unadjusted estimates.
The following 3 approaches were used to adjust RBP for in-
flammation and malaria: exclusion, CF, and regression corrections
(RC) (18). Because of theweak relation between inflammation and
RBP in women, as described in Results, adjustment approaches
were not pursued in the WRA data.
Exclusion approach
The exclusion approach uses the inflammation biomarker in-
formation to exclude individuals with elevated CRP and/or AGP
(defined as a CRP concentration .5 mg/L and/or AGP concen-
tration .1 g/L) from the analysis; this exclusion results in a
smaller sample size. We excluded these individuals and calculated
the estimated prevalence of VAD in the remaining individuals.
CF approach
The CF approach, as proposed by Thurnham et al. (15), uses
arithmetic CFs. We calculated CFs by grouping inflammation
into 4 groups as follows: 1) reference (both CRP concentration
#5 mg/L and AGP concentration #1 g/L); 2) incubation (CRP
concentration .5 mg/L and AGP concentration #1 g/L);
3) early convalescence (both CRP concentration .5 mg/L and
AGP concentration .1 g/L); and 4) late convalescence (CRP
concentration #5 mg/L and AGP concentration .1 g/L). We
also calculated CFs by grouping inflammation or malaria into
2 groups in which CRP, AGP, or malaria was used independently.
CFs were defined as the ratio of geometric means of the reference
group (nonelevated CRP and/or AGP or malaria negative de-
pending on the grouping used) to those of the respective in-
flammation group or malaria-positive group. CFs were calculated
based on internal survey-specific data [termed the Internal Cor-
rection Factor (ICF)], a previous meta-analysis using distinct data
from the BRINDA data set [termed Thurnham Correction Factor
(TCF)] (15), and the meta-analyzed BRINDA data set [termed
BRINDA Correction Factor (BCF)]. The CF approach was per-
formed for CRP alone, AGP alone, and both CRP and AGP. CFs
were additionally calculated for malaria with the use of the ICF
approach only. Although the Thurnham meta-analysis (15) looked
specifically at serum retinol, serum retinol and RBP concentra-
tions have consistently been shown to be highly correlated (29).
Hence, the TCFs have been used to adjust RBP for inflammation.
RC approach
The RC approach uses linear regression to adjust RBP by the
concentration of CRP and/or AGP on a continuous scale and
malaria as a dichotomous variable as defined further in the
BRINDA methods article (18). Briefly, the adjusted RBP equa-
tion was calculated by subtracting the influence of CRP, AGP, and
malaria as follows:
RBPadjusted ¼ RBPunadjusted2b1ðCRPobs2CRPrefÞ
2 b2ðAGPobs2AGPrefÞ2 b3ðmalariaÞ
ð1Þ
Depending on the available data, CRP, AGP, and/or malaria can be
included in the model. b1 is the CRP regression coefficient, b2 is
the AGP regression coefficient, b3 is the malaria regression co-
efficient, obs is the observed value, and ref is the reference value
(maximum value of the lowest CRP or AGP decile with the use of
combined BRINDA data with nonlogged reference values of CRP
in PSC of 0.10 and of AGP in PSC of 0.59). CRP, AGP, and RBP
are all ln transformed; CRP and AGP are continuous variables, and
malaria is a dichotomous variable. The correction was only ap-
plied to individuals with ln CRP greater than ln CRPref and ln AGP
greater than ln AGPref to avoid overadjustments (18). An illustra-
tive example of the use of the RC approach to adjust RBP for AGP
and CRP in PSC in Liberia is provided in Supplemental Figure 1.
The first step in the RC approach was to ln transform RBP, CRP,
and AGP concentrations to approximate normality on the basis of
regression diagnostics. CRP data contained values of zero, and
thus, the survey-specific lowest value was used to replace zeros
before applying the ln transformation. Second, linear regression
coefficients for CRP, AGP, and/or malaria were obtained (bivariate
and multiple) with RBP as the outcome. A test of multicollinearity
between ln CRP and ln AGP or betweenmalaria and ln CRP and/or
ln AGP was assessed on the basis of a test of tolerance (.0.1) and
variance inflation factor (,5) to determine whether it was ap-
propriate to include all variables in the model. Third, a ln CRPref
was subtracted from ln-CRP concentrations, and a ln AGPref was
subtracted from ln-AGP concentrations in the regression equation.
The RC approach is presented based on internal survey specific
data [termed the Internal Regression Correction (IRC)] and the
meta-analyzed BRINDA data [termed BRINDA Regression Cor-
rection (BRC)]. The BRC approach entailed replacing the CRP and
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AGP b coefficients in the adjusted RBP Equation 1 with the meta-
analysis b coefficients. The same external reference values for
CRP and AGP were used when applying both the IRC and BRC
approaches. Each of these RCs was performed for CRP alone,
AGP alone, and both CRP and AGP. The IRC was also per-
formed for malaria alone, and malaria plus CRP and AGP. The
BRC approach was not applied when including malaria in the
model because of the limited number of data sets that measured
malaria.
We also tested whether potential confounders significantly
influenced the relation between RBP and inflammation. We added
sex, age, maternal education, and socioeconomic status to the
model, and the CRP and AGP slopes that were adjusted for these
confounders were extracted and used in the adjusted RBP equation.
Comparison of adjustments
Unadjusted and adjusted prevalence estimates of VAD were
compared with the use of McNemar’s chi-square test; statistical
significance was defined as P , 0.05 before applying the Bonfer-
roni corrections to account for multiple comparisons (P = 0.05O k,
where k equals the number of comparisons). To examine whether
malaria infection remained associated with VAD after adjustment
for CRP and AGP, we stratified the adjusted prevalence of VAD
estimates by malaria status and compared the adjusted VAD prev-
alence with the use of the adjusted Wald test. It was decided a priori
that adjustments for CRP and AGP together and CRP, AGP, and
malaria combined would be explored irrespective of the significance
between malaria and nonmalaria VAD prevalence.
RESULTS
Participant characteristics
Our study samplewas restricted to participants with nomissing
values for RBP, CRP, AGP, or malaria (in surveys that measured
malaria). The analysis included a total of 8803 PSC and 4191
WRA. Participants who were excluded because of missing RBP,
CRP, AGP, or malaria data (6.6%) did not differ from those who
were included with regard to sex, age, or socioeconomic status.
The PSC data sets had a wide disparity in age ranges as follows:
6–12 mo (n = 1 data set), 6–23 mo (n = 1 data set), 6–35 mo
(n = 3 data sets), 12–59 mo (n = 1 data set), and 6–59 mo (n = 2
data sets) (Table 1). The geometric mean of RBP concentrations
was lower in children (0.81–1.02 mmol/L) than in women (1.32–
1.57 mmol/L) in all countries. Similarly, the prevalence of any
inflammation (defined as elevated CRP and/or AGP) was higher
in children (26.0–67.5%) than in women (19.7–33.7%) in all
countries. The prevalence of malaria also differed across surveys
with malaria data (Cameroon, Coˆte d’Ivoire, Kenya, and
Liberia), and ranged from 19.7% to 32.5% in children and from
5.0% to 17.9% in women (Table 1).
Relation between RBP, inflammation, and malaria
In PSC, Kendall’s t coefficients between RBP and CRP
ranged from 20.26 to 20.37, between RBP and AGP ranged
from 20.18 to 20.32, and between CRP and AGP ranged from
0.49 to 0.63 (P , 0.05) (Supplemental Table 1). In WRA, the
correlations of markers of inflammation with RBP were not as
strong and were significant (P , 0.05) for only CRP in some
surveys but not for AGP. Kendall’s t coefficients between RBP
and CRP ranged from 20.02 to 20.13, between RBP and AGP
were close to zero, and between CRP and AGP were close to
0.40 (Supplemental Table 1). In PSC and WRA, there was a
weak relation between malaria and RBP ranging from 20.10
to 20.19 (P , 0.05) in PSC and 20.07 to 0 (P . 0.05) in WRA
(Supplemental Table 1). The estimated prevalence of VAD in
PSC increased with increasing CRP and AGP deciles (Figure
1). The relation between the estimated prevalence of VAD and
inflammation deciles did not vary according to whether sub-
jects were above or below CRP and AGP cutoffs. This relation
was not the case in women (Figure 2). Because of the lack of a
TABLE 1
Age, inflammation, and malaria in preschool children and women of reproductive age: the BRINDA project1
Survey n Age2
CRP
concentration
.5 mg/L
AGP
concentration
.1 g/L
CRP concentration
.5 mg/L or
AGP concentration .1 g/L Malaria
Preschool children
Bangladesh 1493 8.3 (6, 11) 14.3 (11.8, 16.7) 33.4 (29.9, 36.9) 35.8 (32.2, 39.5) —
Cameroon 774 30.8 (12, 59) 37.5 (32.7, 42.3) 39.3 (33.7, 45.0) 48.3 (43.2, 53.5) 25.9 (20.2, 31.5)
Coˆte d’Ivoire 733 31.7 (6, 59) 40.4 (36.5, 44.3) 64.5 (60.3, 68.6) 67.5 (63.8, 71.3) 27.2 (22.3, 32.0)
Kenya 2007 888 19.9 (6, 35) 27.8 (23.9, 31.7) 64.2 (60.2, 68.2) 66.0 (61.9, 70.1) 19.7 (15.8, 23.6)
Kenya 2010 843 21.4 (6, 35) 34.2 (29.6, 38.7) 60.7 (56.0, 65.4) 61.9 (57.2, 66.6) 32.5 (28.4, 36.6)
Liberia 1434 19.9 (6, 35) 29.5 (26.5, 32.5) 56.2 (52.5, 60.0) 59.1 (55.6, 62.7) 29.4 (26.2, 32.6)
Papua New Guinea 871 37.9 (6, 59) 31.6 (27.2, 36.0) 54.1 (49.4, 58.9) 57.0 (52.6, 61.5) —
Philippines 1767 15.0 (6, 23) 13.9 (11.6, 16.2) 21.2 (17.7, 24.6) 26.0 (22.4, 29.5) —
Women of reproductive age
Cameroon 751 27.2 (15, 49) 17.8 (14.8, 20.7) 7.2 (5.1, 9.3) 19.7 (16.6, 22.9) 15.0 (11.3, 18.6)
Coˆte d’Ivoire 816 27.6 (15, 49) 19.7 (16.5, 22.8) 26.9 (23.5, 30.4) 33.7 (29.6, 37.9) 5.0 (3.4, 6.5)
Liberia 1875 28.6 (15, 49) 14.3 (12.1, 16.4) 10.4 (8.7, 12.2) 18.5 (16.2, 20.8) 17.9 (15.3, 20.4)
Papua New Guinea 749 33.5 (15, 49) 10.0 (7.5, 12.5) 21.8 (18.1, 25.6) 24.8 (21.0, 28.7) —
1Values are percentages (95% CIs) unless otherwise indicated. Elevated CRP and AGP concentrations were defined as .5 mg/L and .1 g/L,
respectively. AGP, a-1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive
protein.
2 All values are means (minimum to maximums in parentheses). Age is given in whole months in children and in whole years in women.
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strong and consistent relation between RBP and CRP and AGP in
women, adjustments for inflammation are only presented for
children.
CFs for RBP, inflammation, and malaria
The 4-level ICF values (used in the ICF adjusting for CRP and
AGP approach) and 2-level ICF values (used in the ICF adjusting
for CRP and ICF adjusting for AGP approaches) were.1 across
all categories and surveys in PSC (Supplemental Table 2). The
CFs were also .1 for malaria across all groups and surveys in
PSC (Supplemental Table 3). When individuals were stratified
by malaria status and by 4-inflammation levels, geometric mean
RBP concentrations tended to be lower in the PSC group with
malaria and elevated CRP and AGP concentrations, whereas this
was not the case for women (Table 2). In children, the CFs
(BCFs: incubation: 1.22; early convalescence: 1.38; and late
convalescence: 1.09) were of similar magnitude to the TCFs that
were derived from the previous meta-analysis (15), which used
plasma retinol concentrations from 15 studies of apparently
healthy individuals (incubation: 1.14; early convalescence: 1.31;
and late convalescence: 1.12).
RC slopes for RBP, inflammation, and malaria
A multiple linear regression for the internal regression cor-
rection adjusting for C-reactive protein and a-1-acid glycoprotein
(IRC-CRP+AGP) with ln-RBP as the outcome in PSC resulted
in an unstandardized ln-CRP slope ranging from 20.07 (Coˆte
d’Ivoire) to 20.05 (Kenya 2007) and a ln-AGP slope ranging
from 20.17 (Kenya 2010) to 0.03 (Papua New Guinea) (Supple-
mental Table 4). The addition of malaria to the multiple regression
analysis dampened the ln-CRP and ln-AGP slopes. The bivariate
linear regression (for the IRC adjusting for CRP approach and the
IRC adjusting for AGP approach) resulted in larger negative slopes
for ln-CRP and ln-AGP than in the multiple regression (Supple-
mental Table 5). There was no multicollinearity between ln-CRP
and ln-AGP or between ln-CRP, ln-AGP, and malaria, although the
larger negative slopes that were seen in the bivariate regression
compared with the multiple regression were likely due to ln-CRP
and ln-AGP being correlated. Coefficients for the BRC approach
are presented in Supplemental Table 4 under All Surveys (BRC
adjusting for CRP and AGP) and in Supplemental Table 5 (for
BRC adjusting for CRP and BRC adjusting for AGP).
Unadjusted prevalence of VAD in PSC and VAI in WRA
There was considerable variation in the unadjusted estimated
prevalence of VAD in PSC in data sets. Ignoring inflammation
resulted in an unadjusted estimated VAD prevalence ranging
from 6.9% in the Philippines to 29.5% in Kenya’s 2010 data set
(Table 3). In WRA, the unadjusted VAI prevalence ranged from
7.6% in Papua New Guinea, to 13.3% in Coˆte d’Ivoire, to 16.4%
in Cameroon, to 20.5% in Liberia.
FIGURE 1 Estimated prevalence [percentage (95% CI)] of vitamin A deficiency in preschool children by CRP (A) and AGP (B) deciles: the Biomarkers
Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. The analysis was restricted to surveys (Bangladesh, Cameroon, Coˆte
d’Ivoire, Kenya 2007, Kenya 2010, Liberia, Philippines, and Papua New Guinea) that measured both CRP and AGP for comparability between CRP and AGP
relations with biomarkers (n = 8803). Vitamin A deficiency was defined as an RBP concentration ,0.70 mmol/L. Bold vertical lines indicate commonly used
cutoffs for CRP and AGP. AGP, a-1-acid glycoprotein; CRP, C-reactive protein; RBP, retinol-binding protein.
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Estimated prevalence of VAD in PSC excluding individuals
with inflammation
In PSC, the exclusion of individuals with elevated CRP or AGP
resulted in a sample-size loss of 28–69% (Table 3). In PSC, the
exclusion of individuals with elevated CRP compared with the
inclusion of all children from the survey resulted in a decrease in
the estimated prevalence of VAD, the largest of which was ob-
served in Cameroon (28.5% compared with 10.8%) (Table 3). This
decrease in estimated VAD was also seen when children with
elevated AGP were excluded compared with the inclusion of all
children; the largest decrease was observed in Kenya’s 2010 data
set (29.5% compared with 12.1%, respectively) (Table 3). When
children with elevated CRP and/or AGP were excluded compared
with the inclusion of all children, the largest decrease was ob-
served in Kenya’s 2007 data set (23.0% compared with 6.3%,
respectively) (Table 3).
Effect of adjusting RBP for inflammation with the use of
CRP, AGP, or both CRP and AGP by the CF and RC
approaches
In PSC, adjustment for CRP alone resulted in the smallest
change in VAD in nearly all data sets, which was followed by
the change with AGP adjustments and by the change with ad-
justments for both CRP and AGP compared with unadjusted
values. This same pattern was shown across adjustment methods
(Supplemental Table 2, Supplemental Tables 6–9) except with
the IRC approach whereby adjusting for CRP alone resulted in a
larger decrease in estimated VAD than did adjusting for AGP
alone. For instance, with the use of the IRC approach, adjusting
for only CRP compared with adjusting for only AGP resulted
in a median decrease in the estimated VAD prevalence of 0.8
percentage points (pps). With the use of the IRC approach to
adjust for both CRP and AGP compared with adjusting for only
CRP resulted in a median decrease in the estimated VAD prev-
alence of 1.1 pps (Figure 3, Supplemental Table 8).
Comparison of estimated prevalence of VAD in children
with the use of different approaches to adjust RBP
for inflammation
The prevalence of VAD decreased compared with the un-
adjusted prevalence in PSC when adjusted for CRP and AGP in
all surveys regardless of the adjustment approach (Figures 4 and
5, Table 3, Supplemental Tables 2, 6–9). The exclusion of in-
dividuals with elevated CRP and AGP resulted in a sample size
loss of 28–69% in PSC and, with the use of this method, resulted
in an estimated prevalence of VAD that was 12.6 absolute me-
dian pps (range: 5.5–18.0 pps) lower than the unadjusted prev-
alence (Table 3).
The use of ICFs resulted in amedian decrease of 10.8 pps in the
estimated prevalence of VAD (ranging from 5.1 pps in the
Philippines to 13.6 pps in Kenya 2010) (Supplemental Table 2,
Figure 4). The use of the TCF approach resulted in a lower
FIGURE 2 Estimated prevalence [percentage (95% CI)] of vitamin A insufficiency in women of reproductive age by CRP (A) and AGP (B) deciles: the
Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. The analysis was restricted to countries (Cameroon, Coˆte
d’Ivoire, Liberia, and Papua New Guinea) (n = 4191).Vitamin A insufficiency was defined as an RBP concentration,1.05 mmol/L. Bold vertical lines indicate
commonly used cutoffs for CRP and AGP. AGP, a-1-acid glycoprotein; CRP, C-reactive protein; RBP, retinol-binding protein.
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estimated prevalence of VAD from unadjusted prevalence
values by 4.0 pps in the Philippines where unadjusted VAD was
lowest to 12.2 pps in Kenya 2010 where unadjusted VAD was
the highest (median decrease: 11.0 pps) (Supplemental Table 6).
The use of the BCF approach resulted in a median decrease in
the prevalence of VAD of 11.5 pps (range: 4.6–13.1 pps) from
unadjusted values (Figure 4, Supplemental Table 7). The use
of the IRC approach to adjust RBP concentrations in children
decreased the VAD prevalence by a median of 18.4 pps (range:
6.1–22.1 pps), and the use of the BRC approach decreased the
prevalence by a median of 17.8 pps (range: 6.0–19.4 pps),
compared with unadjusted prevalence values (Figure 4, Sup-
plemental Tables 8, 9).
Adjusted prevalence of VAD in children with the use of
malaria in addition to CRP, AGP, to adjust RBP for
inflammation and malaria
Adjustment for malaria alone with the use of the ICF approach
decreased the estimated prevalence of VAD by an absolute
median of 5.2 pps (range: 3.6–9.6 pps) in PSC (Supplemental
Table 3). We also examined the effect of malaria in addition to
inflammation on RBP concentrations by adjusting RBP con-
centrations with the use of the regression approach and strati-
fying the adjusted prevalence of VAD by malaria status. In
children, after adjusting RBP concentrations with the use of
the IRC approach, the prevalence of VAD significantly differed
(P , 0.05) in children with and without malaria in 4 of 5
country data sets with malaria data (Coˆte d’Ivoire, Kenya
2010, Kenya 2007, and Liberia). In these data sets, the dif-
ference in the adjusted prevalence of VAD (with the use of
IRC) in children with and without malaria ranged from 2%
(Liberia) to 7% (Kenya 2010). However, adjusting for in-
flammation with the use of IRC accounting for both CRP and
AGP resulted in similar point estimates of estimated VAD as
when adjusting for malaria and inflammation both (Supple-
mental Table 3, Figure 5).
Estimated prevalence of VAD with the use of the IRC
approach to adjust RBP for inflammation taking into
account confounders
There was no change in the prevalence of VAD adjusting for
inflammation with the use of the IRC approach in PSC when
controlling for socioeconomic status, maternal education, age,
and sex (maternal education data were unavailable in Bangla-
desh, Liberia, and Papua New Guinea; socioeconomic status data
were unavailable in Bangladesh) than when not controlling for
confounders (data not shown). The absolute median difference of
adjusted VAD controlling for confounders compared with not
controlling for confounders using IRC adjusting for CRP ranged
from 20.3 to 0 pps, using IRC adjusting for AGP ranged from
TABLE 2
RPB in preschool children and women of reproductive age according to
inflammation stage and malaria status: the BRINDA data set1
Inflammatory stage
Malaria-endemic countries
Malaria negative Malaria positive
n RBP, mmol/L n RBP, mmol/L
Preschool children2
Reference 1693 0.96 (0.92, 1.00)3 201 0.91 (0.87, 0.95)
Incubation 123 0.83 (0.76, 0.91) 37 0.80 (0.68, 0.92)
Early convalescence 669 0.74 (0.70, 0.77) 666 0.65 (0.62, 0.68)
Late convalescence 992 0.90 (0.86, 0.95) 291 0.83 (0.79, 0.86)
Women of reproductive
age4
Reference 2401 1.41 (1.32, 1.51) 267 1.33 (1.19, 1.48)
Incubation 230 1.30 (1.20, 1.40) 76 1.13 (1.06, 1.22)
Early convalescence 190 1.19 (1.05, 1.34) 67 1.18 (0.86, 1.61)
Late convalescence 185 1.58 (1.50, 1.67) 26 1.33 (1.07, 1.65)
1 Reference is defined as a CRP concentration #5 mg/L and AGP con-
centration#1 g/L; incubation is defined as a CRP concentration.5 mg/L and
AGP concentration #1 g/L; early convalescence is defined as a CRP concen-
tration .5 mg/L and AGP concentration .1 g/L; and late convalescence is
defined as an AGP concentration .1 g/L and CRP concentration #5 mg/L.
AGP, a-1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation
and Nutritional Determinants of Anemia; CRP, C-reactive protein; RBP, ret-
inol-binding protein.
2 Countries in which malaria was measured in children were Cameroon,
Coˆte d’Ivoire, Kenya 2007, Kenya 2010, and Liberia.
3 Geometric mean; 95% CI in parentheses (all such values)
4 Countries in which malaria was measured in women were Cameroon,
Coˆte d’Ivoire, and Liberia.
TABLE 3
Estimated prevalence of vitamin A deficiency unadjusted and after excluding those with inflammation in preschool children: the BRINDA data set1
Survey
Unadjusted
CRP concentration
#5 mg/L2
AGP concentration
#1 g/L2
CRP concentration
#5 mg/L or AGP
concentration #1 g/L2
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
Bangladesh 1493 17.0 (14.4, 19.7) 1280 12.6 (10.1, 15.1) 994 10.8 (7.7, 13.9) 958 9.6 (6.8, 12.4)
Cameroon 774 28.5 (24.3, 32.7) 493 10.8 (14.3, 22.3) 483 19.2 (14.9, 23.4) 411 16.6 (12.0, 21.2)
Coˆte d’Ivoire 733 24.0 (20.3, 27.8) 429 13.1 (10.1, 16.0) 250 10.4 (6.6, 14.1) 227 8.7 (5.3, 12.0)
Kenya 2007 888 23.0 (19.1, 26.8) 641 12.8 (9.9, 15.7) 318 7.5 (4.4, 10.7) 302 6.3 (3.3, 9.3)
Kenya 2010 843 29.5 (25.7, 33.4) 555 15.7 (12.6, 18.7) 331 12.1 (8.3, 15.8) 321 11.5 (7.9, 15.1)
Liberia 1434 24.7 (21.2, 28.1) 1059 16.5 (13.4, 19.7) 672 12.3 (9.0, 15.5) 633 11.6 (8.4, 14.8)
Papua New Guinea 871 25.0 (20.8, 29.3) 588 15.1 (11.7, 18.5) 395 14.3 (10.4, 18.2) 369 12.9 (8.9, 16.9)
Philippines 1767 6.9 (5.1, 8.7) 1500 2.9 (1.8, 4.0) 1345 2.1 (1.3, 3.0) 1274 1.4 (0.8, 1.9)
1 Vitamin A deficiency was defined as a retinol-binding protein concentration ,0.70 mmol/L. AGP, a-1-acid glycoprotein; BRINDA, Biomarkers
Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein.
2 Vitamin A deficiency in the subset of samples with nonelevated inflammatory biomarkers.
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20.1 to 0.4 pps, and using IRC-CRP+AGP ranged from 20.2
to 0.2 pps.
DISCUSSION
The findings from this large, multicountry analysis show that
RBP concentrations were lower in individuals with elevated CRP
and AGP concentrations and/or malaria than in individuals with
low inflammation. The adjustment of RBP concentrations with
the use of any of the statistical approaches described decreased
the estimated prevalence of VAD compared with unadjusted
values in children. This decreasewas most striking with the use of
the RC approach. The adjustments estimated VAD by mathe-
matically removing or reducing the effect of elevated CRP and
AGP in population surveys of PSC, which is important for de-
cisions regarding nutrition interventions, programs, and policies.
The first question we explored with this analysis was whether
there is a need to measure biomarkers of inflammation when
measuring RBP. We showed a strong correlation of both CRP and
AGP with RBP in all countries in children, which was expected
because of the biological response of the body to inflammation.
During the acute-phase response, RBP concentrations may be
temporarily reduced because of decreased RBP synthesis, de-
creased release of the retinol-RBP complex into the circulation,
and leakage of RBP into the extravascular space (13). Therefore,
during an inflammatory episode, the concentration of RBP is not
reflective of the individual’s usual RBP concentration. Because
of the effect of the acute-phase response on RBP concentrations,
the estimation of VAD prevalence in child populations with high
levels of inflammation is likely to be overestimated if no ad-
justment is made for APPs. However, we showed weak corre-
lations between CRP and AGP with RBP in all surveys with data
for women. In addition, the relations between VAI prevalence
and CRP decile and VAI prevalence and AGP decile were not
linear and did not support the use of the regression method
to adjust for inflammation when measuring RBP in women. The
reasons for this weak relation and the different patterns in
women and children are not well understood but may include the
lower prevalence of both inflammation and VAD in women, a
more developed immune system in women that allows them to
combat infection more efficiently, the potential role of other
effect modifiers such as obesity, and the smaller number of
surveys. Other authors (15) have suggested applying the same
CFs to children and women to adjust serum retinol for inflam-
mation. However, our results suggest that the relations between
RBP and CRP and AGP may be different in women than in
children. We require additional analyses to explore the potential
etiology and whether and how to adjust the results to account for
inflammation in populations of women.
Second, we examined the need to measure .1 inflammation
biomarker (CRP and/or AGP) to adjust RBP for inflammation in
children. The substantial changes in estimates of VAD prevalence
from adjustment with the use of the CF and RC approaches than
with no adjustment highlight the importance of measuring in-
flammation. In most cases, adjusting for CRP and AGP together
resulted in the largest reduction in the prevalence of VAD in chil-
dren. Both CRP and AGP are important in explaining the variability
in RBP, and their correlation with RBP was similar across countries.
CRP has been widely measured and should continue to be measured
in conjunction with AGP to better understand their relation with
RBP. It would be important to also further investigate the relation
between RBP and other inflammatory biomarkers in other settings.
Third, we examined the importance of additional adjustment to
correct RBP concentrations in the presence of malaria. Our re-
sults show that RBP was associated with malaria independently
from CRP and AGP, which was consistent with a recent study that
also examined this relation (30). This association could reflect an
added influence of malaria-related inflammation on temporary
reductions in RBP concentrations that is not captured by CRP and
AGP (31). However, the adjustment of RBP for malaria, in ad-
dition to CRP and AGP, with the use of the RC approach results in
minimal changes in the estimated prevalence of VAD in children
FIGURE 3 Estimated prevalence [percentage (95% CI)] of vitamin A deficiency on the basis of IRC-CRP, IRC-AGP, or IRC-CRP1AGP in preschool
children: the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Vitamin A deficiency prevalence was defined
as retinol binding protein ,0.7 mmol/L. Bars without a common lowercase letter within a given survey differ, P , 0.05 (adjusted by using Bonferroni
correction). Internal regression correction reference values were as follows: C-reactive protein:22.26 ln(mg/L) [QE (df = 10) = 439.90, P, 0.0001]; a-1-acid
glycoprotein: 20.52 ln(g/L) [QE (df = 10) = 584.5546, P , 0.0001]. IRC-AGP, internal regression correction adjusting for a-1-acid glycoprotein; IRC-CRP,
internal regression correction adjusting for C-reactive protein; IRC-CRP+AGP, internal regression correction adjusting for C-reactive protein and a-1-acid
glycoprotein; QE, QE test of residual heterogeneity.
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compared with values when adjusting for CRP and AGP only.
Therefore, there seems to be little added benefit of further
adjusting for malaria status to correct RBP concentrations.
Our last question compared adjustment approaches that are
used to calculate the prevalence of VAD in the presence of in-
flammation. In our analysis, the reduction in the estimated
prevalence of VAD after adjustment with the use of the RC ap-
proach was strong in PSC; in the majority of surveys, the prev-
alence of VAD dropped by 10–20 pps after adjustment with the
use of the IRC adjusting for CRP and AGP approach compared
with unadjusted values. Wessells et al. (30) showed a similar
drop in VAD prevalence of 11 pps in children 6–23 mo of age in
Burkina Faso after adjusting for inflammation with the use of the
TCFs adjusting for CRP and AGP approach.
The categorical CFs adjust RBP concentrations on the basis of
4 stages of inflammation that are defined by cutoffs of CRP
concentrations .5 mg/L and AGP concentrations .1 g/L. ICFs
depend on the inflammation levels and distribution of the pop-
ulation being measured. As such, their precision depends on the
number of individuals who fall into each of the 4 stages of in-
flammation; if this number is too small, the ICFs may not adjust
for inflammation correctly. Further, RBP concentrations in
children showed a decreasing trend, and VAD prevalence showed
an increasing trend, with increasing CRP and AGP concentrations
on a continuous scale irrespective of the predefined cutoffs (16–
18). Specifically, even in children with CRP and AGP concen-
trations that were less than the common concentration cutoffs of
5 mg/L and 1 g/L, respectively, CRP and AGP were associated
negatively with RBP concentrations. Furthermore, the cutoff of a
CRP concentration .5 mg/L was defined at a time when the
laboratory methods could not accurately measure lower concen-
trations (32), and the cutoff for AGP was arbitrarily defined.
These associations and the limitations that are inherent in cutoffs
provide justification that the RC approach may offer some
advantage and precision, by adjusting RBP in a continuous
manner that better reflects the association between RBP and APPs
over the entire range of APP concentrations.
The severity of inflammation in children seemed to alter RBP
concentrations. In PSC, there was consistency in the strength of the
linear relation (i.e., slopes with the use of the IRC approach) be-
tween RBP and CRP and AGP between countries. The heteroge-
neity statistic was significant for slopes between countries for PSC,
and therefore, the application of an external slope (BRC approach)
is not suggested at this time. However, because of the results in
PSC, the BRC adjusting for CRP and AGP approach should be
further explored in other countries, and if findings are similar to
those presented here, the approach could be considered for use
across populations. Further investigation is needed to examine
potential modifiers of the relation between RBP and CRP and AGP
from other causes of inflammation such as tissue injury, intestinal
parasites, respiratory infections, aflatoxin, and HIV. RBP may also
be altered in the presence of other conditions such as obesity (33)
and by age, which should be considered in future investigations.
Although liver vitamin A stores most accurately depict an
individual’s vitamin A status (4), serum retinol is the recom-
mended biomarker for determining population-level VAD (20).
However, the high costs of the measurements of retinol with the
use of HPLC and stability issues make retinol more difficult
to use in large population studies than RBP (7). Therefore, RBP
is often measured in nutritional surveys and is used to estimate
the vitamin A status of a population. To our knowledge, there
is currently no consensus on RBP cutoffs to indicate VAD;
thus, the VAD-prevalence values that we presented should be
interpreted with caution. Our study assumed a molar ratio of
retinol:RBP of 1:1 (5, 29); however, different ratios of RBP:
retinol have been proposed (23, 34), and some research has
suggested that the ratio of RBP and retinol may change during the
response to inflammation (35) as the ratio of holo-RBP to apo-RBP
FIGURE 4 Estimated prevalence [percentage (95% CI)] of vitamin A deficiency with the use of different inflammation-adjustment approaches adjusting
for CRP and AGP in preschool children: the Biomarkers Reflecting Inflammation and Nutrition Determinants of Anemia (BRINDA) project. Vitamin A
deficiency was defined as retinol binding protein ,0.7 mmol/L. Bars without a common lowercase letter within a given survey differ, P , 0.05 (adjusted by
using Bonferroni correction). BCFs were as follows: incubation phase: 1.22 (95% CI: 1.16, 1.28); early convalescence phase: 1.38 (95% CI: 1.31, 1.44); and
late convalescence phase: 1.09 (95% CI: 1.06, 1.11) [QE (df = 28) = 261.6964, P , 0.0001). IRC and BRC reference values were as follows: ln CRP = 22.26
ln(mg/L) [QE (df = 10) = 439.90, P, 0.0001]; ln AGP =20.52 ln(g/L) [QE (df = 10) = 584.5546, P, 0.0001]. BRC coefficients were as follows: ln CRP =20.06;
and ln AGP = 20.09 [QE (df = 21) = 240.4563, P , 0.0001]. AGP, a-1-acid glycoprotein; BCF, Biomarkers Reflecting Inflammation and Nutritional
Determinants of Anemia correction factor; BRC, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia regression correction; CRP,
C-reactive protein; ICF, internal correction factor; IRC, internal regression correction; QE, QE test of residual heterogeneity.
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changes. When different cutoffs for RBP are used, the regression
approach still results in the largest adjustment of the estimated
prevalence of VAD. For example, when the Engle-Stone et al.
(23) concentration cutoff of 0.83 mmol/L for RBP was used, we
observed a median decrease of 25.8 pps (range: 14.0–31.1 pps)
with a higher prevalence of estimated VAD overall.
A limitation of the analysis is the nature of cross-sectional
data, which does not provide evidence for assessing a causal
effect of the inflammatory response on RBP concentrations.
The role of vitamin A on the immune response has been well
documented (36) and is indicative of the importance of the re-
verse relation or the effect of VAD on infection. In some cases,
the adjustment approaches we present could lead to over-
correction and an underestimation of VAD in certain commu-
nities. However, because of the biological plausibility and the large
drops we saw in the VAD prevalence after adjustment, we expect
the effect of the acute-phase response on RBP to be crucial and
warrant the proposed adjustments. Ideally, the use of longitudinal
data to examine more deeply the relation between RBP and the
acute-phase response could address whether the relation between
RBP and biomarkers of inflammation is different between in-
dividuals with different vitamin A–status pre-inflammation as well
as different causes of inflammation. Although these statistical
adjustments are used to create estimates of the prevalence of VAD
in population-based studies of children, they do not represent the
exact biological influence of inflammation on RBP. The adjust-
ments depicted in this analysis are meant for population-based
estimates and are not meant for clinical settings or for the esti-
mation of the vitamin A status of individual children. The current
results that were derived from adjustments with CFs and the RC
were based on the country data that were available and, therefore,
are representative only of the countries presented here. However,
because of the similarity in the findings for the countries included
and the biological basis for these adjustments, we expect that the
same approaches are appropriate for other populations of children
with high levels of inflammation.
Nonetheless, the findings of this study highlight the importance
of inflammation in interpreting RBP concentrations in populations
of children in settings with inflammation. The RC approach allows
for a continuous adjustment of RBP by concentrations of CRP and
AGP, and this approach appears to yield findings that are suffi-
ciently different from the CF approaches to produce different
conclusions on a population’s vitamin A status. These 2 points,
and the heterogeneity in BRINDA regression coefficients, support
the use of the IRC accounting for both CRP and AGP approach to
adjust RBP concentrations and to estimate an adjusted prevalence
of VAD in populations of PSC with inflammation (option A).
However, the IRC approach requires statistical expertise until
there has been a development of a ready-to-use macro. In cases
where no such expertise is available, the ICF approach could be
used as an alternative approach in children (option B). The ICF
approach accounts for population-specific inflammation profiles
of which the BCF approach does not, but in case of surveys with a
small sample size, the BCF approach can be used. We suggest the
use of the newly derived BCFs that are presented in Supplemental
Table 7 because they were designed for PSC specifically unlike
those shown in the Thurnham et al. (15) meta-analysis, which
combined data from pregnant and nonpregnant women, children,
neonates, and HIV-positive adults. Any follow-up surveys should use
the same approach to monitor trends and maintain comparability.
In conclusion, in settings where inflammation or malaria are
present, the burden of VAD may be overestimated. This over-
estimation is particularly critical in contexts in which vitamin A
intervention programs are in place because the expected effects
of these programs on vitamin A–status indicators may not be
observed if inflammation is ignored; concerns have been raised
regarding the potential of excessive vitamin A exposure if vita-
min A intervention programs are delivered to individuals with
FIGURE 5 Estimated prevalence [percentage (95% CI)] of vitamin A deficiency in preschool children with the use of different malaria-adjustment
approaches. Vitamin A deficiency was defined as retinol-binding protein ,0.7 mmol/L. Bars without a common lowercase letter within a given survey differ,
P , 0.05 (adjusted by using Bonferroni correction). Internal regression correction reference values were as follows: ln C-reactive protein = 22.26 ln(mg/L)
[QE (df = 10) = 439.90, P , 0.0001]; and ln a-1-acid glycoprotein = 20.52 ln(g/L) [QE (df = 10) = 584.5546, P , 0.0001]. IRC-CRP+AGP, internal
regression correction adjusting for C-reactive protein and a-1-acid glycoprotein; IRC-CRP+AGP+malaria, internal regression correction adjusting for C-re-
active protein, a-1-acid glycoprotein, and malaria; IRC-malaria, internal regression correction adjusting for malaria; QE, QE test of residual heterogeneity.
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adequate status (37). When data are available and appropriate, a
reanalysis of past vitamin A interventions to include the adjustment
approach recommended here could yield new insights; relative
effects may be larger or smaller from those that were previously
shown. The WHO cutoffs to define the degree to which VAD is a
public health problem in a population have been prepared on the
basis of VAD-prevalence estimates that were unadjusted for in-
flammation (5); therefore, the cutoffs may not be appropriate
compared with adjusted values. A revised recommendation is an
issue for the WHO to consider in the future. Thus, the adjusted
prevalence estimates presented here cannot be compared with
previous estimates that do not account for inflammation (38). This
study is meant as a step forward in comparing different ap-
proaches to accurately and feasibly assess the prevalence of VAD
in populations for CRP and AGP and, when appropriate, malaria.
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